SCHEMBL6994658

SCHEMBL6994658

COC1=CC[CH]C(c2ccc(Cl)c(Cl)c2)=C1OC

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.38
PDGFRB P09619 1/20 0.37
PDGFRA P16234 1/20 0.37
MAPK10 P53779 3/20 0.35
CYP1B1 Q16678 1/20 0.34
SLC6A3 Q01959 7/20 0.34
SLC6A2 P23975 4/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
MAPK14 Q16539 1/20 0.34
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
AKR1C3 P42330 1/20 0.32
AKR1C2 P52895 1/20 0.32
KMO O15229 1/20 0.32
F2RL3 Q96RI0 1/20 0.32
NOTUM Q6P988 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6047593 0.80 ALKBH3 (0.36) AHRPDGFRBPDGFRAMAPK10CYP1B1
SCHEMBL5887273 0.80 AHR (0.34) AHRPDGFRBPDGFRAMAPK10CYP1B1
SCHEMBL5887524 0.77 RAD51 (0.37) AHRADORA2AADORA1
SCHEMBL18229239 0.77 PDE4B (0.37)
SCHEMBL5887082 0.70 CLK4 (0.35)
SCHEMBL5887298 0.70 RAD51 (0.40) AHRADORA2AADORA1
SCHEMBL5887386 0.69 RAD51 (0.36) AKR1C2
SCHEMBL4802145 0.69 AHR (0.41) AHRPDGFRBPDGFRAMAPK10CYP1B1
SCHEMBL5887155 0.69 NOTUM (0.36) MAPK10SLC6A3SLC6A2MAPK9MAPK14
SCHEMBL5887645 0.69 RAD51 (0.37) AHRADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347967-A1 NOVEL BENZAZEPINES AND RELATED HETEROCYCLIC DERIVATIVES WHICH ARE USEFUL AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2003-10-01 EP disclosed
WO-2002051838-A1 NOVEL BENZAZEPINES AND RELATED HETEROCYCLIC DERIVATIVES WHICH ARE USEFUL AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2002-07-04 WO disclosed